Solid Biosciences

Solid’s mandate is to improve the lives of patients living with devastating neuromuscular and cardiac diseases. #TogetherWeAreSolid

[Solid Biosciences @Solid_Bio]

Recently, we joined @PPDCRO at their GMP Lab in Middleton, WI, for a discussion with patient advocates in the #FriedreichsAtaxia (FA) community. This panel featured firsthand perspectives from those impacted by FA and insights into our work in FA, fostering a deeper understanding of the patient and caregiver experience.

We're proud to be part of important conversations that strengthen collaboration and advance our shared goal of improving outcomes for people in need. Thank you to Sam, Aiden and Rachel for sharing your stories! #FACommunity #RareDisease

[Solid Biosciences @Solid_Bio]

Solid Biosciences today announced our financial results for the second quarter of 2026, along with business and pipeline updates.

Read the full release: https://t.co/E9K25NKPYU

#SolidBiosciences $SLDB

[Solid Biosciences @Solid_Bio]

This weekend, #TeamSolid had a great time at the fourth annual rideATAXIA Hometown Boston bike ride, hosted by Friedreich's Ataxia Research Alliance (FARA).

We're proud to join FARA and the local Boston community in advancing Friedreich's ataxia (FA) research.

#FriedreichsAtaxia #FACommunity

[Solid Biosciences @Solid_Bio]

We’re proud to sponsor The Akari Foundation’s Duchenne Family Education & Community Connection Event on August 1, bringing together individuals and families in the Duchenne community to learn, connect and access valuable resources.

The Akari Foundation is dedicated to educating and empowering the Hispanic community affected by rare neuromuscular diseases, providing them with equitable access to information, awareness and advocacy for comprehensive support.

We look forward to connecting with the Duchenne community throughout the event.

Learn more about The Akari Foundation: https://t.co/PBKp6HKqLp

#RareDisease #PatientAdvocacy #Duchenne #MuscularDystrophy

[Solid Biosciences @Solid_Bio]

With summer officially underway, we want to recognize the incredible impact our spring co-op cohort made over the past several months. Their hard work directly supported our mission to improve the lives of patients living with rare diseases.

Day in and day out, they brought dedication, curiosity and passion to our teams. We are proud of their accomplishments during their time with us and wish them nothing but the best as they take the next steps in their careers!

#TogetherWeAreSolid #SolidInside #SolidStartsHere

[Solid Biosciences @Solid_Bio]

Solid Biosciences is looking forward to attending the 2026 Leerink Partners Therapeutics Forum in Boston on July 15, where members of the management will participate in 1x1 investor meetings.

If you will be attending, we’d welcome the chance to connect.

#SLDB #SolidBiosciences #Biotech #RareDisease #LeerinkPartners

[Solid Biosciences @Solid_Bio]

We are proud to sponsor the 2026 What NOW? Virtual Conference hosted by @TeamJosephInfo, taking place July 15–16.

Led by a committee of older adolescents and adults living with Duchenne, this event focuses on navigating the transition into adulthood, exploring key topics such as independence, higher education, career paths and relationships.

You can learn more and register for the conference here: https://t.co/mLpBaEQFhJ

#WhatNOW2026 #Duchenne #RareDiseaseCommunity

[Solid Biosciences @Solid_Bio]

Our Head of Corporate Strategy and Business Development, Shuli Roditi-Kulak, MD, MBA, recently joined leaders from across the industry at the @IAmBiotech (BIO) International Convention to discuss the future of biotech innovation and leadership.

During the session, "At the Helm of Biopharma: Insights from Women Leading Science, Strategy and Scale," Shuli shared her perspective on how the biotech ecosystem must evolve to meet the next era of innovation. As scientific complexity increases, radical collaboration can unlock new models that empower companies to leverage shared knowledge and capabilities to accelerate progress for patients.

Our #SolidInside efforts reflect this philosophy. We are working to expand access to next-generation enabling technologies that create new pathways for partnership across precision genetic medicine, allowing companies to focus more resources on innovation and less on rebuilding foundational infrastructure.

#BIO2026

[Solid Biosciences @Solid_Bio]

Thank you to @ParentProjectMD (PPMD) for a meaningful and engaging 2026 Annual Conference. Our team was grateful for the opportunity to connect with patients, families, advocates, clinicians and researchers from across the Duchenne community.

During the conference, Kevin Flanigan, MD, of @nationwidekids and Principal Investigator in the Phase 1/2 INSPIRE DUCHENNE clinical trial, presented an overview of the SGT-003 development program during the Gene Therapy: Today & Tomorrow session. The presentation helped foster important discussions about ongoing research and the future of Duchenne treatment development.

We're thankful to PPMD for bringing the community together and look forward to continuing these important conversations in support of individuals and families impacted by Duchenne.

#PPMD2026 #Duchenne #GeneTherapy #RareDisease #DuchenneCommunity

[Solid Biosciences @Solid_Bio]

As we head into the @ParentProjectMD (PPMD) Annual Conference, we are sharing the latest update with the Duchenne Community, including an overview of recent progress in our SGT-003 clinical development program.

We are deeply grateful for our partnerships with patients, families and our clinical sites, and look forward to engaging at PPMD this weekend.

Read more here: https://t.co/Vyww0ztve2

[Solid Biosciences @Solid_Bio]

#TeamSolid was proud to take part in the @BAA's 10K, presented by Mass General Brigham Cancer Institute!

All funds raised will support efforts to advance groundbreaking research, deliver leading-edge care, and improve outcomes for patients and families facing cancer.

Congratulations to everyone who raced and thank you to the B.A.A. for bringing together such an incredible event and community.

#BAA10K #MassGeneralCancerInstitute #CardiacHealth